2022
DOI: 10.1016/j.vhri.2021.04.006
|View full text |Cite
|
Sign up to set email alerts
|

Direct Medical Cost of Type 2 Diabetes Mellitus and Its Associated Complications in Indonesia

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
28
1
4

Year Published

2023
2023
2024
2024

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 41 publications
(33 citation statements)
references
References 14 publications
(21 reference statements)
0
28
1
4
Order By: Relevance
“…Diabetes treatment is a costly health issue for which the Indonesian government is responsible. The total direct medical cost in Indonesia is US$ 576 million, with 56% spent on hospitalisation, 38% on specialist visits, 4% on unbundled non‐diabetes‐related medications and 2% on unbundled anti‐hyperglycaemic medications 9 . Patients with wound complications are handled improperly or by unqualified healthcare professionals and face severe complications, which can lead to longer treatment and result in higher medical costs 7,8 .…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Diabetes treatment is a costly health issue for which the Indonesian government is responsible. The total direct medical cost in Indonesia is US$ 576 million, with 56% spent on hospitalisation, 38% on specialist visits, 4% on unbundled non‐diabetes‐related medications and 2% on unbundled anti‐hyperglycaemic medications 9 . Patients with wound complications are handled improperly or by unqualified healthcare professionals and face severe complications, which can lead to longer treatment and result in higher medical costs 7,8 .…”
Section: Introductionmentioning
confidence: 99%
“…The total direct medical cost in Indonesia is US$ 576 million, with 56% spent on hospitalisation, 38% on specialist visits, 4% on unbundled non-diabetes-related medications and 2% on unbundled anti-hyperglycaemic medications. 9 Patients with wound complications are handled improperly or by unqualified healthcare professionals and face severe complications, which can lead to longer treatment and result in higher medical costs. 7,8 DFUs not only impose a heavy financial burden on patients and the healthcare system, but also significantly decrease quality of life (QOL), and increase morbidity and mortality.…”
mentioning
confidence: 99%
“…The high and rapidly increasing number of Type 2 diabetes cases aggregates the care burden and impacts the daily life of sufferers. Diabetes was the third leading cause of death in 2016, and about U.S. $576 million of the Indonesian health insurance (Jaminan Kesehatan Nasional) budget was spent treating this disease (Hidayat et al, 2022; Mboi et al, 2018), highlighting the importance of proper management to diabetes-related complication prevention and optimal health outcomes.…”
Section: Introductionmentioning
confidence: 99%
“…While the burden of CKD is reasonably well defined in developed countries, 1 increasing evidence indicates that the CKD burden may be even greater in developing countries. 3 The 2014-2018 Indonesia National Health Insurance Statistics results show a substantial increase in the number of patients, the number of visits, the average number of visits per person/year and the cost of claims for dialysis procedures, 4 inherent with the increasing financial burden for CKD treatment, with an average claim value per patient in a year as much as Rp. 48,714,515 or equivalent to USD 3,365.…”
Section: Introductionmentioning
confidence: 99%